Literature DB >> 19220827

A report on transmissible spongiform encephalopathies and transfusion safety.

J Coste1, C Prowse, R Eglin, C Fang.   

Abstract

The incidence of BSE in Europe is in continued decline. At present, iatrogenic transmission from person to person is considered a serious threat to public health. This report of the International Society of Blood Transfusion Working Party on Transmissible Spongiform Encephalopathy will focus on the state of the art in relation to blood components and plasma safety. Latest information on the pathogenicity of the infectious agent, the frequency and dynamics of infection in blood and transfusion transmissibility will be documented. Preventive measures including donor deferral policies, technologies for prion removal from labile blood components and for prion detection in plasma, the absence of a sensitive and rapid reference assay able to confirm the positive results from any putative blood screening assay will be updated. At last, as many uncertainties remain and a number of assumptions await confirmation, the areas to continue to explore are listed.

Entities:  

Mesh:

Year:  2009        PMID: 19220827     DOI: 10.1111/j.1423-0410.2009.01161.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  4 in total

1.  B cells and platelets harbor prion infectivity in the blood of deer infected with chronic wasting disease.

Authors:  Candace K Mathiason; Jeanette Hayes-Klug; Sheila A Hays; Jenny Powers; David A Osborn; Sallie J Dahmes; Karl V Miller; Robert J Warren; Gary L Mason; Glenn C Telling; Alan J Young; Edward A Hoover
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

2.  Management and prevention of human prion diseases.

Authors:  Silvia Graziano; Maurizio Pocchiari
Journal:  Curr Neurol Neurosci Rep       Date:  2009-11       Impact factor: 5.081

3.  Sufficient blood, safe blood: can we have both?

Authors:  Halvard Bönig; Michael Schmidt; Kai Hourfar; Jörg Schüttrumpf; Erhard Seifried
Journal:  BMC Med       Date:  2012-03-23       Impact factor: 8.775

4.  Re-assessment of PrP(Sc) distribution in sporadic and variant CJD.

Authors:  Richard Rubenstein; Binggong Chang
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.